Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to CPRX Full portfolio

Position in CPRX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$14,387,862
+$7,188,150 QoQ
Shares Held
581,093
+88.4% QoQ
Ownership
0.475%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CPRX Over Time

Shares Held

Position Value (USD)

Derivatives in CPRX

reported options exposure · as of Mar 31, 2026
CallValue
$304,548
CallShares
12,300
PutValue
$940,880
PutShares
38,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. CPRX ranks #75 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in CPRX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,387,862 581,093
2026-03-31 $940,880 38,000
2026-03-31 $304,548 12,300
2025-12-31 $1,159,998 49,700
2025-12-31 $7,199,712 308,471
2025-12-31 $270,744 11,600
2025-09-30 $344,750 17,500
2025-09-30 $352,630 17,900
2025-09-30 $7,838,550 397,896
2025-06-30 $5,641,826 259,992
2025-06-30 $486,080 22,400
2025-03-31 $16,621,337 685,416
2025-03-31 $514,100 21,200
2025-03-31 $227,950 9,400
2024-12-31 $9,109,065 436,467
2024-12-31 $279,658 13,400
2024-12-31 $244,179 11,700
2024-09-30 $153,076 7,700
2024-09-30 $306,152 15,400
2024-09-30 $501,731 25,238
2024-06-30 $102,234 6,600
2024-06-30 $130,116 8,400
2024-06-30 $9,029,446 582,921
2024-03-31 $181,716 11,400
2024-03-31 $1,071,168 67,200
2024-03-31 $17,827,933 1,118,440
2023-12-31 $603,479 35,900
2023-12-31 $353,010 21,000
2023-12-31 $8,574,848 510,104
2023-09-30 $469,938 40,200
2023-09-30 $162,491 13,900
2023-09-30 $5,620,820 480,823
2023-06-30 $2,218,862 165,094
2023-06-30 $650,496 48,400
2023-06-30 $436,800 32,500
2023-03-31 $7,122,983 429,613
2023-03-31 $1,084,332 65,400
2023-03-31 $437,712 26,400
2022-12-31 $472,440 25,400
2022-12-31 $952,320 51,200
2022-12-31 $850,893 45,747
2022-09-30 $427,239 33,300
2022-09-30 $528,596 41,200
2022-06-30 $121,273 17,300
2022-06-30 $133,891 19,100
2022-06-30 $1,359,582 193,949
2022-03-31 $1,769,184 213,412
2022-03-31 $164,971 19,900
2021-12-31 $150,294 22,200
2021-12-31 $1,273,998 188,183

Report a Problem

Category
Description
Email (optional, for follow-up)